Colon cancer gene was identified
On Dec. 7, 1993, Dana-Farber scientists identified the gene that causes an inherited form of colon cancer, which…
-
-
Clinical Research | Disease | FDA | IRB | Medicine | Oncology | Therapeutics | Women's Health
FDA issued guidelines calling for improved assessments of medication responses as a function of gender
On Jul. 22, 1993, revising a policy from 1977 that excluded women of childbearing potential from early drug…
-
The NIH Revitalization Act of 1993 was signed
On Jun. 10, 1993, the U.S. Congress signed the National Institutes of Health Revitalization Act, P.L. 103-43. The…
-
The first gene associated with hereditary nonpolyposis colon cancer was cloned (hMSH2)
On May 7, 1993, the first gene associated with hereditary nonpolyposis colon cancer (HNPCC) was cloned (hMSH2). People…
-
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the U.S. Food and Drug Administration (FDA) approved Amgen’s Epogen/Procrit for the treatment of…
-
The Pappajohn Clinical Cancer Center opens for service
In 1993, the John and Mary Pappajohn Clinical Cancer Center opened for service after receiving a generous $25…
-
Immunex merged with American Cyanamid’s Lederle Oncology business
On Dec. 21, 1992, Immunex announced a merger agreement with American Cyanamid Company’s Lederle Oncology business. In Nov….
-
Biotechnology | Clinical Research | Diagnostics | Oncology | Radiology | Therapeutics | Women's Health
The Prostate, Lung, Colorectal, and Ovarian trial began recruiting 148,000 men and women, ages 55-74
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched. The trial was designed to determine whether…
-
Washington University School of Medicine announced as a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study)
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
-
Bristol-Myers Squibb launched TAXOL (paclitaxel)
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
The Hollings Cancer Center was founded
In 1993, The Hollings Cancer Center (HCC) was formally was established and named for former U.S. Senator and…
-
Vanderbilt Cancer Center was established
In 1993, the Vanderbilt Cancer Center was established under the leadership of Dr. Hal Moses, to bring together…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The Cancer Therapy & Research Center at San Antonio received NCI designation
In 1993, The Cancer Therapy & Research Center (CTRC) at San Antonio received National Cancer Institute (NCI) designation….
-
Jon M and Karen Huntsman donated $10 million to the University of Utah to establish a cancer institute
In 1993, Jon M. and Karen Huntsman donated $10 million to the University of Utah to establish a…
-
Biotechnology | Disease | FDA | Forestry | Oncology | Therapeutics | Women's Health
Taxol (paclitaxel) approved by the FDA for the treatment of ovarian cancer that has failed other therapy
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…
-
Biotechnology | Diagnostics | Medical Device | Medicine | Non-Profit Research | Oncology | Orthopedic | Radiology | Therapeutics | U.S. Congress
The Veteran’s Affairs Medical Center bridge at OHSU opened
On Nov. 2, 1992, the Veteran’s Affairs Medical Center bridge opened. The 660-foot-long suspended pedestrian enclosed skybridge is…
-
Diagnostics | FDA | NIH | Oncology | Radiology | U.S. Congress | Women's Health
The Mammography Quality Standards Act was passed by the US Congress
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress…
-
OHSU President Peter O Kohler, MD appointed Grover Bagby, MD, director of the Oregon Cancer Center
In 1992, Oregon Health & Science University (OHSU) President Peter O. Kohler, M.D. announced the appointment of Grover…
-
The Oregon Cancer Center was founded at Oregon Health & Science University
In 1992, the Oregon Cancer Center, later known as the OHSU Cancer Institute, was founded at Oregon Health…
-
Dendreon Corporation was founded
In 1992, Dendreon was founded, and its lead product, Provenge, was an immunotherapy for prostate cancer. Dendreon filed…
-
Pacific Health Research Institute was awarded the multi-center ‘Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial’
In 1992, the National Cancer Institute (NCI) awarded the Pacific Health Research Institute its largest and most enduring…
-
Biotechnology | NIH | Oncology | Therapeutics
The Indiana University Cancer Center was founded
In 1992, The Indiana University (IU) Cancer Center, now known as the IU Melvin and Bren Simon Comprehensive…
-
Cell Therapeutics was incorporated
On Sept. 4, 1991, Cell Therapeutics, also known as CTI BioPharma, was incorporated by two oncologists, Drs. James…
-
Biotechnology | FDA | Oncology | Therapeutics
Immunex received FDA approval to market Leukine (GM-CSF) in the U.S.
On Mar. 6, 1991, Immunex announced it had received U.S. Food and Drug Administration (FDA) approval to market…
-
Post-operative (adjuvant) radiation therapy and chemotherapy are found to improve survival in rectal cancer
On Mar. 4, 1991, researchers reported that post-operative (adjuvant) radiation therapy and chemotherapy were found to improve survival…
-
Biotechnology | FDA | Oncology | Stem Cell | Therapeutics
FDA approved White blood cell colony-stimulating factors (G-CSF and GM-CSF)
On Feb. 22, 1991, the Food and Drug Administration (FDA) announced that it had approved Amgen’s two white…
-
The University of Michigan Rogel Cancer Center received Comprehensive NCI designation
In 1991, the University of Michigan Rogel Cancer Center received National Cancer Institute (NCI) comprehensive center designation. The…
-
US Senator Alan Cranston underwent state-of-the-art procedure at Stanford University Hospital to attack his prostate cancer
In 1991, U.S. Senator Alan Cranston (D-Calif.) underwent a state-of-the-art procedure at Stanford University Hospital to attack his…
-
The CDC began developing a national strategic plan for early detection and control of breast and cervical cancers
In 1991, the U.S. Centers for Disease Control and Prevention (CDC) began developing a national strategic plan for…
-
Stoddard Cancer Center opened at Iowa Methodist Medical Center
In 1991, Stoddard Cancer Center, now part of UnityPoint Health, opened at Iowa Methodist Medical Center. In 1990,…
